CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes

被引:47
|
作者
Liu, Che [1 ]
Luo, Defang [1 ]
Streit, Wolfgang J. [2 ]
Harrison, Jeffrey K. [1 ]
机构
[1] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA
关键词
chemokine; GL261; glioblastoma multiforme; tumor immunology;
D O I
10.1016/j.jneuroim.2008.04.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human glioblastoma multiforme (GBM) is the most malignant form of human brain tumors. A characteristic of GBM is the marked presence of tumor infiltrated microglia/macrophages and lymphocytes. The goal of this study was directed toward understanding the role of the chemokine system CX3CL1 and its receptor CX3CR1 in the GL261 murine model of malignant glioma. In situ hybridization analysis identified CX3CL1 and CX3CR1 expression in GL261 tumors. The impact of CX3CR1 deletion on the growth of intracranial GL261 gliomas and associated immune cell infiltration was evaluated in CX3CR1 gene-disrupted C57BL/6 mice. A slight increase in the tumor growth rate in CX3CR1-/- mice was evident with similar numbers of microglia and CD4(+), CD8(+), FoxP3(+), or Ly49G2(+) lymphocytes within tumors established in CX3CR1 +/- and -/- mice. These data indicate that CX3CR1 has little or no effects on either gliomagenesis or the migration of microglia and lymphocytes into GL261 tumors. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 50 条
  • [41] Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability
    Zhang, Xiaolin
    Feng, Xueyao
    Cai, Wenzhi
    Liu, Tengfei
    Liang, Zhenyang
    Sun, Ying
    Yan, Chenghui
    Han, Yaling
    THROMBOSIS RESEARCH, 2015, 135 (06) : 1147 - 1153
  • [42] Spinal CX3CL1/CX3CR1 May Not Directly Participate in the Development of Morphine Tolerance in Rats
    Yawen Peng
    Genhua Guo
    Bin Shu
    Daiqiang Liu
    Peng Su
    Xuming Zhang
    Feng Gao
    Neurochemical Research, 2017, 42 : 3254 - 3267
  • [43] Microglia, seen from the CX3CR1 angle
    Wolf, Yochai
    Yona, Simon
    Kim, Ki-Wook
    Jung, Steffen
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7
  • [44] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Wojdasiewicz, Piotr
    Poniatowski, Lukasz A.
    Kotela, Andrzej
    Deszczynski, Jaroslaw
    Kotela, Ireneusz
    Szukiewicz, Dariusz
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (05) : 395 - 403
  • [45] CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1
    Sciume, Giuseppe
    Soriani, Alessandra
    Piccoli, Mario
    Frati, Luigi
    Santoni, Angela
    Bernardini, Giovanni
    NEURO-ONCOLOGY, 2010, 12 (07) : 701 - 710
  • [46] Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
    Sato, Michihito
    Ohtsuka, Kumiko
    Takahashi, Ryo
    Wakabayashi, Kuninobu
    Odai, Tsuyoshi
    Isozaki, Takeo
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2011, 3 : 1 - 7
  • [47] CX3CL1 and CX3CR1 could be a relevant molecular axis in the pathophysiology of idiopathic pulmonary fibrosis
    Rivas-Fuentes, Selma
    Herrera, Iliana
    Salgado-Aguayo, Alfonso
    Buendia-Roldan, Ivette
    Becerril, Carina
    Cisneros, Jose
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (15): : 2357 - 2361
  • [48] EVALUATION OF THE ROLE OF FRACTALKINE CHEMOKINE CX3CL1 AND ITS RECEPTOR CX3CR1 IN INFLAMMATORY MYOPATHIES
    Colafrancesco, S.
    Priori, R.
    Astorri, E.
    Scrivo, R.
    D'Amati, G.
    Giordano, C.
    Valesini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 568 - 568
  • [49] CX3CL1/CX3CR1在脑缺血中的作用及其机制
    杨桐
    李琼
    杨海梅
    朱洁
    李敬诚
    张莉莉
    国际脑血管病杂志, 2021, 29 (07) : 537 - 543
  • [50] Correlation of CX3CL1 and CX3CR1 Levels with Response to Infliximab Therapy in Patients with Rheumatoid Arthritis
    Odai, Tsuyoshi
    Matsunawa, Mizuho
    Takahashi, Ryo
    Wakabayashi, Kuninobu
    Isozaki, Takeo
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1158 - 1165